These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6776564)

  • 21. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
    Cappendijk SL; de Vries R; Dzoljic MR
    Neurosci Lett; 1993 Nov; 162(1-2):97-100. PubMed ID: 7510058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral changes produced in the cat by acute and chronic morphine injection and naloxone precipitated withdrawal.
    French ED; Vasquez SA; George R
    Eur J Pharmacol; 1979 Aug; 57(4):387-97. PubMed ID: 573695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.
    Higgins GA; Nguyen P; Joharchi N; Sellers EM
    Psychopharmacology (Berl); 1991; 105(3):322-8. PubMed ID: 1839177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of naloxone-precipitated withdrawal jumping by i.c.v. and i.t. administration of saline in morphine-dependent mice.
    Miyamoto Y; Takemori AE
    Life Sci; 1993; 52(13):1129-34. PubMed ID: 8450707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice.
    el Kadi AO; Sharif SI
    Pharmacol Biochem Behav; 1996 Sep; 55(1):49-54. PubMed ID: 8870037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes induced by sodium cromoglycate on brain serotonin turnover in morphine dependent and abstinent mice.
    San-Martin-Clark O; Leza JC; Lizasoain I; Lorenzo P
    Psychopharmacology (Berl); 1993; 111(2):233-8. PubMed ID: 7532863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An electromyographic method for the assessment of naloxone-induced abstinence in morphine-dependent rats.
    Menon MK; Tseng LF; Loh HH; Clark WG
    Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):43-9. PubMed ID: 7190227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal exposure to morphine or naloxone intensifies morphine dependence at maturity.
    Koyuncuoğlu H; Aricioğlu F
    Pharmacol Biochem Behav; 1993 Apr; 44(4):939-41. PubMed ID: 8469703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinal cord thyrotropin releasing hormone receptors of morphine tolerant-dependent and abstinent rats.
    Rahmani NH; Gulati A; Bhargava HN
    Peptides; 1990; 11(4):693-5. PubMed ID: 2172939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenothiazine-type antipsychotics may attenuate naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Wu SZ; Chen KT; Chen JY; Sung KC; Wang JJ; Liu KS; Chu CC
    Acta Anaesthesiol Taiwan; 2012 Dec; 50(4):167-71. PubMed ID: 23385039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The acoustic startle response as a measure of behavioral dependence in rats.
    Mansbach RS; Gold LH; Harris LS
    Psychopharmacology (Berl); 1992; 108(1-2):40-6. PubMed ID: 1410145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
    Yamaguchi T; Hagiwara Y; Tanaka H; Sugiura T; Waku K; Shoyama Y; Watanabe S; Yamamoto T
    Brain Res; 2001 Aug; 909(1-2):121-6. PubMed ID: 11478928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats.
    Aricioglu-Kartal F; Uzbay IT
    Life Sci; 1997; 61(18):1775-81. PubMed ID: 9365224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of antihistaminics on naloxone-induced withdrawal in morphine-dependent mice.
    Leza JC; Lizasoain I; Lorenzo P
    Psychopharmacology (Berl); 1990; 102(1):106-11. PubMed ID: 1975446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
    Cicero TJ; Aleem A; Meyer ER; Schmoeker PF; Miller BT
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1063-70. PubMed ID: 3528453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agmatine reduces only peripheral-related behavioral signs, not the central signs, of morphine withdrawal in nNOS deficient transgenic mice.
    Aricioglu F; Paul IA; Regunathan S
    Neurosci Lett; 2004 Jan; 354(2):153-7. PubMed ID: 14698461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.